New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology

Perrine Janiaud; Stylianos Serghiou; John P A Ioannidis

doi:10.1016/j.ctrv.2018.12.003

Back

New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology

Article 2018 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

The coming era of precision medicine for intensive care

Jean Louis Vincent

Article2018

In the Era of Precision Medicine and Big Data, Who Is Normal?

Arjun K. Manrai, Chirag J. Patel, John P A Ioannidis

Article2014

The Next Generation of Sepsis Clinical Trial Designs

Steven M. Opal, R. Phillip Dellinger, Jean Louis Vincent, Henry Masur, Derek C. Angus

Chapter in a book2004

Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Designs

Peter J Barnes, Edward M. Erin, Trevor T. Hansel, Sergei A. Kharitonov, Andrew J. Tan, Rachel Tennant

Article2025

Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action

Winette T.A. van der Graaf, Nina S Heiss, C. Hynes, S.M. Keller, Ariane Weinman, Jean Yves Blay, Pedro Franco, Rachel H. Giles, Denis Lacombe, Philipp Schlatter, David M. Thomas, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Max Williamson, Ruth Plummer